Evidence map›Paper›PMID 41312659›Full record

ArticleEuropean journal of neurology2025

Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis Patients.

Valentina Poretto, Walter Endrizzi, Matteo Betti, Stefano Bovo, Angelo Bellinvia, Flavio Ragni, Caterina Lapucci, Monica Moroni, Sabrina Marangoni, Emilio Portaccio and 10 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Mechanistic Insights into the Role of Artificial Intelligence and Machine Learning in the Diagnosis and Management of Multiple Sclerosis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Valentina PorettoNeurology Unit, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy.
Walter EndrizziData Science for Health, Fondazione Bruno Kessler, Trento, Italy.
Matteo BettiDepartment of NEUROFARBA, University of Florence, Florence, Italy.
Stefano BovoData Science for Health, Fondazione Bruno Kessler, Trento, Italy.
Angelo BellinviaDepartment of NEUROFARBA, University of Florence, Florence, Italy.
Flavio RagniData Science for Health, Fondazione Bruno Kessler, Trento, Italy.ORCID 0000-0001-7767-7288
Caterina LapucciIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Monica MoroniData Science for Health, Fondazione Bruno Kessler, Trento, Italy.
Sabrina MarangoniNeurology Unit, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy.
Emilio PortaccioDepartment of NEUROFARBA, University of Florence, Florence, Italy.
Chiara LongoNeurology Unit, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy.ORCID 0000-0001-6904-6494
Lorenzo GiosData Science for Health, Fondazione Bruno Kessler, Trento, Italy.
Marco ChiericiData Science for Health, Fondazione Bruno Kessler, Trento, Italy.
Giuseppe JurmanData Science for Health, Fondazione Bruno Kessler, Trento, Italy.
Bruno GiomettoNeurology Unit, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy.
Matilde IngleseIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Venet OsmaniData Science for Health, Fondazione Bruno Kessler, Trento, Italy.
Manuela MarencoIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Antonio UccelliIRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Maria Pia AmatoDepartment of NEUROFARBA, University of Florence, Florence, Italy.

Funding

Ministero della Salute NET-2018-12366666 NeuroArtP3Ministry of Health
6 · The paper itself

Abstract

backgroundPredicting prognosis in people with multiple sclerosis (pwMS) at early disease stages still remains an unmet need. Machine learning (ML) strategies demonstrated good reliability when applied for prediction in medicine. This study aimed at developing a predictive algorithm comparing different ML approaches, by using routine demographic, clinical and radiological data from a large multicentric cohort of newly diagnosed pwMS.

methodsDemographic, clinical, radiological and biochemical data were retrospectively collected at three Italian MS centers at baseline and four timepoints thereafter (6, 12, 24, and 36 months). Data from the first evaluation and subsequent 2-year follow-up were analyzed, comparing different ML models (Random Forest, Extra Trees, XGBoost, Logistic Regression and Support Vector Classifier) to predict progression independent of relapse activity (PIRA) at year 3. To understand how features impacted the selected model's output, a ML explainability analysis was performed on the whole cohort and on specific subsets of patients, those aged under 45 and those NEDA-3 at the 2-year follow-up.

resultsData from 719 pwMS (age 34.6 ± 11.2 years); female sex 501 (70%) were analyzed. Ninety-two pwMS (13%) developed PIRA at year 3. Random Forest achieved the highest score, with a test set area under the ROC curve (AUC) of 0.75 ± 0.06. Features with the highest predictive impact were Expanded Disability Status Scale at 24 months, age at symptom onset and disease duration at baseline.

conclusionOur results showed the feasibility of applying ML techniques to predict short-term PIRA in newly diagnosed pwMS by using routine clinical practice data, paving the way for tailored and personalized approaches.

Indexed as

Disease ProgressionMachine LearningMultiple SclerosisAdultFemaleHumansMaleMiddle AgedPrognosisRecurrenceRetrospective Studiesmachine learningmultiple sclerosispersonalizedpredictionprognosisprogression independent of relapse activity

Identifiers

PMID41312659
PMCPMC12661373

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.